Quantum stocks are becoming the market’s next optionality trade — and that is exactly the risk
Quantum is trading less like an industry being valued on commercial proof and more like an AI-adjacent call option on the next compute platform. That can keep money flowing into IONQ, RGTI, QBTS, and QUBT for longer than bears expect, but it also leaves the group exposed to sharp valuation air pockets if the narrative cools even a little.
The market is starting to treat quantum the way it treated several AI-adjacent trades before fundamentals caught up: as a scarce way to buy strategic compute optionality. That is why the group can stay bid despite thin earnings support, ugly margins, and commercialization timelines that are still more roadmap than operating reality. The problem is that optionality works both ways. When investors pay for a future that is still hard to time, the upside can look enormous right up until the market decides the wait is longer than it thought.
The cleanest tell is valuation versus business maturity. IONQ
now carries a roughly $19.29 billion market cap with a trailing P/S of 103.07, even though the core case for the stock still rests on what quantum computing could become rather than what it is today. Yes, the company’s recent revenue momentum is real: Q1 2026 revenue reached $64.7 million, up 755% year over year, and management raised full-year revenue guidance to $260 million-$270 million. But the same quarter also included a $96.8 million adjusted EBITDA loss. That is not a mature platform compounding cash flow; it is a well-funded strategic story that investors are willing to capitalize far in advance.
That pattern gets even more extreme across the rest of the basket. RGTI, QBTS, and QUBT are not being priced like conventional hardware businesses; they are being priced like long-dated claims on a future compute stack. The multiples make that plain:
That last comparison matters. GOOG is profitable, generates a 37.9% net margin, and is explicitly tying quantum into a broader AI-and-compute platform narrative. The pure-play quantum names, by contrast, are mostly loss-making and still proving out commercial demand. Yet some of them trade at sales multiples that make even aggressive growth software look restrained. That is not the market discounting near-term fundamentals. It is the market paying up for strategic scarcity and thematic spillover.
Retail enthusiasm is helping extend that spillover. Once AI became the market’s dominant narrative, investors started looking for the next layer out: semis, power, networking, and now adjacent compute. Quantum fits perfectly because it offers a simple pitch — if AI needs ever more compute, then owning the next compute frontier feels like buying tomorrow before institutions fully price it. We think that logic explains why the group can remain buoyant even with uneven stock performance this year. A trade does not need broad fundamental agreement to work; it just needs enough buyers willing to underwrite the story.
The bulls are not wrong about everything. IONQ has a formidable balance sheet with $3.1 billion in cash, cash equivalents, and investments, which lowers immediate financing risk. RGTI held $569.0 million in cash and investments while pushing its 108-qubit system into general availability and laying out a path toward a 1,000-plus-qubit system in three to four years. QBTS posted 1,994% bookings growth in Q1 2026, and QUBT has built substantial liquidity while using capital to expand strategically. Those are real signs of progress, and they help explain why betting against the group purely on timing has been dangerous.
But that is exactly why we think the risk is being misread. Stronger balance sheets do not make these stocks cheap; they simply give the narrative more time. RGTI still reported just $4.4 million of Q1 revenue against a $26.0 million operating loss. QBTS generated eye-catching bookings growth, but it also carried $56.5 million of GAAP operating expenses in the quarter. And the profitability profile across the group remains brutal, with net margins of -2253.6% for RGTI, -2957.2% for QBTS, and -916.2% for QUBT. Investors are not paying for current operating leverage. They are paying because these stocks function like listed options on a technology race that may take years to sort out.
That can absolutely keep working. Optionality trades often run longer than skeptics think because the market does not need proof of mass adoption every quarter; it only needs enough technical milestones, partnership headlines, and capital-market confidence to preserve the dream. But the same setup creates fragility. If AI enthusiasm broadens into quantum, valuations can levitate on possibility. If that enthusiasm narrows back toward businesses with visible earnings power, the air can come out quickly because there is not much fundamental support underneath these multiples. When a stock at 600-plus times sales disappoints, the issue is not whether the technology is real. The issue is that the valuation already assumed the market would keep suspending disbelief.
Our view is not that quantum is fake or that every name in the group is doomed. It is that the market is increasingly treating IONQ, RGTI, QBTS, and QUBT as AI-adjacent optionality vehicles first and operating businesses second. That distinction matters because optionality can be worth a lot, but it is also the first thing to get repriced when sentiment shifts.
What would change our mind? A sustained move from technical promise to repeatable commercial scale: revenue growth that stays strong without ballooning losses, clearer evidence that bookings convert into durable demand, and valuations that stop assuming strategic inevitability. Until then, we think the trade can stay alive — and that is exactly why the risk is higher than the bulls want to admit.
Our take, not advice. This is opinion commentary — informational only, not personalized investment recommendations. Markets carry risk. Do your own research and consider your own situation before any trade.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
